Outcomes of salvage chemotherapy and autologous stem cell transplantation for relapsed or refractory primary mediastinal large B cell lymphoma (PMLCL) are inferior to diffuse large B cell lymphoma (DLBCL).

被引:0
|
作者
Kuruvilla, J
Nagy, T
Pintilie, M
Keating, A
Crump, M
机构
[1] Univ Toronto, Princess Margaret Hosp, Autologous Blood & Marrow Transplant Program, Toronto, ON, Canada
[2] Princess Margaret Hosp, Clin Study Coordinat, Toronto, ON M4X 1K9, Canada
关键词
D O I
10.1182/blood.V106.11.2085.2085
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2085
引用
收藏
页码:590A / 590A
页数:1
相关论文
共 50 条
  • [41] Autologous stem cell transplantation in patients with relapsed diffuse large B-cell lymphoma:: a multicentre analysis
    Jantunen, E.
    Keskinen, L.
    Kuittinen, T.
    Kuittinen, O.
    Mokka, M.
    Vasala, K.
    Janes, R.
    Remes, K.
    Nousiainen, T.
    Lehtinen, T.
    Leppa, S.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S254 - S254
  • [42] Zanubrutinib Plus Salvage Chemotherapy in Refractory/Relapsed Diffuse Large B-Cell Lymphoma Patients Non-Candidate for Autologous Stem Cell Transplantation: A Retrospective Study
    He, Sha
    Sun, Jie
    Zhong, Dani
    Rong, Chao
    Liao, Chengcheng
    Tan, Xiaohong
    BLOOD, 2023, 142
  • [43] Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 498 - 505
  • [44] Blinatumomab in relapsed/refractory diffuse large B cell lymphoma
    Van Dijck, Ruben
    Janssens, Ann
    Dierickx, Daan
    Delforge, Michel
    Gheysens, Olivier
    Tousseyn, Thomas
    Verhoef, Gregor
    ANNALS OF HEMATOLOGY, 2017, 96 (10) : 1759 - 1762
  • [45] Blinatumomab in relapsed/refractory diffuse large B cell lymphoma
    Ruben Van Dijck
    Ann Janssens
    Daan Dierickx
    Michel Delforge
    Olivier Gheysens
    Thomas Tousseyn
    Gregor Verhoef
    Annals of Hematology, 2017, 96 : 1759 - 1762
  • [46] Efficacy of Salvage Radiotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Wang, S.
    Chen, J. Y.
    Cao, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E471 - E472
  • [47] Efficacy of salvage radiotherapy for relapsed/refractory diffuse large B-cell lymphoma
    Wang, Shu-Bei
    Chen, Jia-Yi
    Zhao, Wei-Li
    Kirova, Youlia M.
    Cao, Wei-Guo
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (04) : 1019 - 1026
  • [48] AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN POOR-PROGNOSIS DIFFUSE LARGE-B CELL LYMPHOMA (DLBCL)
    Perez-Ceballos, E.
    Amigo, M. L.
    Sanchez-Blanco, J. J.
    Castilla, C.
    Heras, I.
    De Arriba, F.
    Nieto, J. B.
    Vicente, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 633 - 633
  • [49] Toxicity and long-term outcomes of elderly patients with refractory or relapsed diffuse large B cell lymphoma undergoing autologous stem cell transplantation
    Huntington, Scott F.
    Hu, Boyu
    Landsburg, Daniel J.
    Mato, Anthony R.
    Nasta, Sunita D.
    Schuster, Stephen J.
    Stadtmauer, Edward A.
    Svoboda, Jakub
    CANCER RESEARCH, 2015, 75
  • [50] Role of Salvage Radiation Treatment of Relapses in Relapsed/Refractory Diffuse Large B Cell Lymphoma Post-Autologous Stem Cell Transplant
    Ladbury, Colton
    Thiruvengadam, Swetha Kambhampati
    Othman, Tamer
    Hao, Claire
    Chen, Lu
    Wong, Jeffrey
    Cao, Thai
    Herrera, Alex
    Mei, Matthew
    Dandapani, Savita
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 113 (03): : 594 - 601